Polycystic Kidney, Autosomal Dominant
Showing 26 - 50 of 9,537
Polycystic Liver Disease, Autosomal Dominant Polycystic Kidney Trial in Nijmegen, Groningen (Leuprorelin)
Recruiting
- Polycystic Liver Disease
- Autosomal Dominant Polycystic Kidney
-
Nijmegen, Gelderland, Netherlands
- +1 more
Jul 27, 2022
Autosomal Dominant Polycystic Kidney Disease Trial in Los Angeles (Pravastatin, sodium citrate)
Enrolling by invitation
- Autosomal Dominant Polycystic Kidney Disease
- Pravastatin
- sodium citrate
-
Los Angeles, CaliforniaKeck School of Medicine of University of Southern California
Jan 24, 2022
ADPKD, Autosomal Dominant Polycystic Kidney Trial in Denver (Pravastatin, Placebo)
Recruiting
- ADPKD
- Autosomal Dominant Polycystic Kidney
- Pravastatin
- Placebo
-
Denver, ColoradoUniversity of Colorado Denver Anschutz Medical Campus
Jan 6, 2022
PErfusioN, OxyGen ConsUmptIon and ENergetics in ADPKD (PENGUIN)
Recruiting
- Polycystic Kidney Disease, Adult
- Polycystic Kidney, Autosomal Dominant
- Aminohippurate Sodium Inj 20%
- +2 more
-
Aurora, ColoradoChildren's Hospital Colorado
Jan 3, 2022
Polycystic Kidney, Autosomal Dominant Trial in Aurora (Metformin, Placebo)
Completed
- Polycystic Kidney, Autosomal Dominant
- Metformin
- Placebo
-
Aurora, ColoradoUniversity of Colorado Denver, Anschutz Medical Campus
Aug 10, 2021
Polycystic Kidney Disease, Adult Trial in Bethlehem (Lixivaptan)
Active, not recruiting
- Polycystic Kidney Disease, Adult
-
Bethlehem, PennsylvaniaNortheast Clinical Research Center, LLC
Jun 7, 2022
Autosomal Dominant Polycystic Kidney Disease, Nephrogenic Diabetes Insipidus, Acquired Nephrogenic Diabetes Insipidus Trial in
Recruiting
- Autosomal Dominant Polycystic Kidney Disease
- +3 more
-
Rochester, MinnesotaMayo Clinic Rochester
Feb 14, 2022
Autosomal Dominant Polycystic Kidney Disease Trial in Ranica (Tolvaptan, Octreotide LAR, Placebo)
Completed
- Autosomal Dominant Polycystic Kidney Disease
- Tolvaptan
- +2 more
-
Ranica, Bergamo, ItalyCRC per le Malattie Rare Aldo e Cele Daccò
Mar 10, 2022
Autosomal Dominant Polycystic Kidney Disease Trial in New York
Active, not recruiting
- Autosomal Dominant Polycystic Kidney Disease
-
New York, New YorkWeill Cornell Medicine
Jul 29, 2021
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Trial in Korea, Republic of (Tolvaptan)
Completed
- Autosomal Dominant Polycystic Kidney Disease (ADPKD)
-
Busan, Korea, Republic of
- +17 more
Jun 15, 2022
Polycystic Liver Disease, Polycystic Kidney, Autosomal Dominant Trial in Nijmegen, Amsterdam, San Sebastian (Ursodeoxycholic
Completed
- Polycystic Liver Disease
- Polycystic Kidney, Autosomal Dominant
- Ursodeoxycholic Acid
-
Nijmegen, Gelderland, Netherlands
- +2 more
Sep 16, 2021
Human Intestinal and Salivary Microbiota Biobank - Kidney
Completed
- Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- +3 more
- Biological sample collection
- +2 more
-
Bari, Italy
- +1 more
Jul 29, 2022
Canadian Medical Assessment of JINARC™ Outcomes Registry
Recruiting
- Autosomal Dominant Polycystic Kidney Disease (ADPKD)
-
Edmonton, Alberta, Canada
- +14 more
Jan 14, 2022
ADPKD (Autosomal Dominant Polycystic Kidney Disease) Trial in Germany
Recruiting
- ADPKD (Autosomal Dominant Polycystic Kidney Disease)
-
Müllheim, Baden-Wuerttemberg, Germany
- +11 more
Sep 20, 2022
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Trial in Worldwide (Phase A Tolvaptan, Placebo Phase A, Phase B Tolvaptan)
Completed
- Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- Phase A Tolvaptan
- +2 more
-
Gent, Oost-Vlaanderen, Belgium
- +19 more
Jan 4, 2022
Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol
Recruiting
- Adenine Phosphoribosyltransferase Deficiency
- +83 more
-
Bristol, South West, United KingdomZoe Plummer
Sep 26, 2023
Polycystic Kidney Disease, Autosomal Dominant Trial in United States (RGLS4326)
Completed
- Polycystic Kidney Disease, Autosomal Dominant
-
La Mesa, California
- +11 more
Dec 14, 2021
Polycystic Kidney Diseases Trial in Kansas City
Recruiting
- Polycystic Kidney Diseases
-
Kansas City, MissouriPKD Foundation
Apr 18, 2022
Congenital Cystic Kidney Disease Trial in Worldwide (Venglustat GZ402671)
Terminated
- Congenital Cystic Kidney Disease
- Venglustat GZ402671
-
Morgantown, West Virginia
- +13 more
Dec 8, 2021
Autosomal Dominant Polycystic Kidney Disease Trial in Worldwide (Placebo, GLPG2737)
Active, not recruiting
- Autosomal Dominant Polycystic Kidney Disease
- Placebo
- GLPG2737
-
Brussels, Belgium
- +19 more
Nov 23, 2021
Polycystic Kidney Disease Data Repository
Recruiting
- Polycystic Kidney Disease
-
New York, New YorkThe Rogosin Institute
Feb 28, 2022
Polycystic Kidney Disease Trial in Indianapolis (Pioglitazone, Placebo)
Completed
- Polycystic Kidney Disease
- Pioglitazone
- Placebo
-
Indianapolis, IndianaIndiana University Health
Dec 22, 2020
IgA Nephropathy, CKD Associated With Type 1 Diabetes, Focal Segmental Glomerulosclerosis Trial in United States (Bardoxolone
Completed
- IgA Nephropathy
- +3 more
- Bardoxolone methyl capsules
-
Birmingham, Alabama
- +29 more
Mar 15, 2022
Polycystic Kidney, Autosomal Dominant Trial in Worldwide (Venglustat GZ402671, Placebo)
Terminated
- Polycystic Kidney, Autosomal Dominant
- Venglustat
- Placebo
-
Birmingham, Alabama
- +94 more
Feb 1, 2023
Polycystic Kidney, Autosomal Dominant, ADPKD, Autosomal Dominant Polycystic Kidney Trial in Groningen (Sodiumchloride, Protein,
Unknown status
- Polycystic Kidney, Autosomal Dominant
- +2 more
- Sodiumchloride
- +3 more
-
Groningen, NetherlandsUMC Groningen
Nov 4, 2020